Cite
HARVARD Citation
Moor, M. et al. (2021). Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study. Lancet. pp. e789-e797. [Online].